| Materelli Home Health Services, Inc | |
| 113 S Broadway, Suite B, Cleveland, Oklahoma 74020 | |
| (580) 448-2600 | |
| Name | Materelli Home Health Services, Inc |
|---|---|
| Location | 113 S Broadway, Suite B, Cleveland, Oklahoma |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 377782 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 73130, 74008, 74011, 74014, 74016, 74019, 74020, 74033, 74035, 74038, 74039, 74044, 74047, 74054, 74055, 74063, 74067, 74070, 74081, 74101, 74105, 74106, 74107, 74115, 74116, 74129, 74130, 74135, 74137, 74146 |
| Quality Rating: |
News Archive
Residents of Bay County, Fla., and surrounding communities will have access to the advanced care of the University of Alabama at Birmingham Cancer Care Network now that Gulf Coast Medical Center in Panama City has joined as its first Florida affiliate.
Cordis Corporation has entered into a distribution agreement with Ostial Solutions for the worldwide distribution of the OSTIAL PRO Stent Positioning System™. The OSTIAL PRO™ is the world's first and only aorto-ostial stent positioning system for coronary and peripheral applications. The OSTIAL PRO™ is intended to optimize the treatment of patients who require a stent implantation for treatment for aorto-ostial blockages.
Retinoblastoma protein RB1, which is named after a form of pediatric tumor of the eye, is among the most common genetically regulated cellular proteins to malfunction in human cancer. RB1 was also the first tumor suppressor gene to be identified and its modes of inactivation in retinoblastoma tumors provided the basis for the ground-breaking two-hit hypothesis by the geneticist Alfred G. Knudson in the 70s, according to which cancer is due to the accumulation of multiple 'hits' or mutations in certain genes.
Ben Zaitchik, a professor of Earth and planetary sciences at Johns Hopkins University, is available to speak with the media about the vigorous research still needed to definitively determine if and how climate, environmental and meteorological elements influence the spread of COVID-19.
Today, the U.S. Food and Drug Administration approved Opdivo (nivolumab), in combination with certain types of chemotherapy, for the initial treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer and esophageal adenocarcinoma.
› Verified 1 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 96.7 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 98.4 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 84 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 74.1 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
Residents of Bay County, Fla., and surrounding communities will have access to the advanced care of the University of Alabama at Birmingham Cancer Care Network now that Gulf Coast Medical Center in Panama City has joined as its first Florida affiliate.
Cordis Corporation has entered into a distribution agreement with Ostial Solutions for the worldwide distribution of the OSTIAL PRO Stent Positioning System™. The OSTIAL PRO™ is the world's first and only aorto-ostial stent positioning system for coronary and peripheral applications. The OSTIAL PRO™ is intended to optimize the treatment of patients who require a stent implantation for treatment for aorto-ostial blockages.
Retinoblastoma protein RB1, which is named after a form of pediatric tumor of the eye, is among the most common genetically regulated cellular proteins to malfunction in human cancer. RB1 was also the first tumor suppressor gene to be identified and its modes of inactivation in retinoblastoma tumors provided the basis for the ground-breaking two-hit hypothesis by the geneticist Alfred G. Knudson in the 70s, according to which cancer is due to the accumulation of multiple 'hits' or mutations in certain genes.
Ben Zaitchik, a professor of Earth and planetary sciences at Johns Hopkins University, is available to speak with the media about the vigorous research still needed to definitively determine if and how climate, environmental and meteorological elements influence the spread of COVID-19.
Today, the U.S. Food and Drug Administration approved Opdivo (nivolumab), in combination with certain types of chemotherapy, for the initial treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer and esophageal adenocarcinoma.
› Verified 1 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 76.8 | 79.6 |
| How often patients got better at getting in and out of bed | 68.3 | 81.1 |
| How often patients got better at bathing | 61 | 82.3 |
| How often patients’ breathing improved | 56.4 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 58.1 | 75 |
| How often home health patients had to be admitted to the hospital | 19.8 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 6.4 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 95.1 | 94 |
News Archive
Residents of Bay County, Fla., and surrounding communities will have access to the advanced care of the University of Alabama at Birmingham Cancer Care Network now that Gulf Coast Medical Center in Panama City has joined as its first Florida affiliate.
Cordis Corporation has entered into a distribution agreement with Ostial Solutions for the worldwide distribution of the OSTIAL PRO Stent Positioning System™. The OSTIAL PRO™ is the world's first and only aorto-ostial stent positioning system for coronary and peripheral applications. The OSTIAL PRO™ is intended to optimize the treatment of patients who require a stent implantation for treatment for aorto-ostial blockages.
Retinoblastoma protein RB1, which is named after a form of pediatric tumor of the eye, is among the most common genetically regulated cellular proteins to malfunction in human cancer. RB1 was also the first tumor suppressor gene to be identified and its modes of inactivation in retinoblastoma tumors provided the basis for the ground-breaking two-hit hypothesis by the geneticist Alfred G. Knudson in the 70s, according to which cancer is due to the accumulation of multiple 'hits' or mutations in certain genes.
Ben Zaitchik, a professor of Earth and planetary sciences at Johns Hopkins University, is available to speak with the media about the vigorous research still needed to definitively determine if and how climate, environmental and meteorological elements influence the spread of COVID-19.
Today, the U.S. Food and Drug Administration approved Opdivo (nivolumab), in combination with certain types of chemotherapy, for the initial treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer and esophageal adenocarcinoma.
› Verified 1 days ago
News Archive
Residents of Bay County, Fla., and surrounding communities will have access to the advanced care of the University of Alabama at Birmingham Cancer Care Network now that Gulf Coast Medical Center in Panama City has joined as its first Florida affiliate.
Cordis Corporation has entered into a distribution agreement with Ostial Solutions for the worldwide distribution of the OSTIAL PRO Stent Positioning System™. The OSTIAL PRO™ is the world's first and only aorto-ostial stent positioning system for coronary and peripheral applications. The OSTIAL PRO™ is intended to optimize the treatment of patients who require a stent implantation for treatment for aorto-ostial blockages.
Retinoblastoma protein RB1, which is named after a form of pediatric tumor of the eye, is among the most common genetically regulated cellular proteins to malfunction in human cancer. RB1 was also the first tumor suppressor gene to be identified and its modes of inactivation in retinoblastoma tumors provided the basis for the ground-breaking two-hit hypothesis by the geneticist Alfred G. Knudson in the 70s, according to which cancer is due to the accumulation of multiple 'hits' or mutations in certain genes.
Ben Zaitchik, a professor of Earth and planetary sciences at Johns Hopkins University, is available to speak with the media about the vigorous research still needed to definitively determine if and how climate, environmental and meteorological elements influence the spread of COVID-19.
Today, the U.S. Food and Drug Administration approved Opdivo (nivolumab), in combination with certain types of chemotherapy, for the initial treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer and esophageal adenocarcinoma.
› Verified 1 days ago
Bios Home Health Care Llc Location: 121 South Broadway, Cleveland, Oklahoma 74020 Ratings: Phone: (918) 358-2483 | |
Materelli Home Health Services, Inc Location: 113 S Broadway, Suite B, Cleveland, Oklahoma 74020 Ratings: Phone: (580) 448-2600 |